Enhancing immunotherapy for CLL patients with ibrutinib
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
Lessening the economic burden of treating CLL
The iwCLL 2017 meeting
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?